Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
Am J Respir Crit Care Med. 2022 May 15;205(10):1202-1213. doi: 10.1164/rccm.202104-0971OC.
Knowledge gaps exist regarding health implications of sleep-disordered breathing (SDB) identified in pregnancy and/or after delivery. To determine whether SDB in pregnancy and/or after delivery is associated with hypertension (HTN) and metabolic syndrome (MS). nuMoM2b-HHS (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be Heart Health Study) ( = 4,508) followed participants initially recruited during their first pregnancy. Participants returned for a visit 2-7 years after pregnancy. This study examined a subgroup who underwent SDB assessments during their first pregnancy ( = 1,964) and a repeat SDB assessment after delivery ( = 1,222). Two SDB definitions were considered: ) apnea-hypopnea index (AHI) ⩾ 5 and ) oxygen desaturation index (ODI) ⩾ 5. Associations between SDB and incident HTN and MS were evaluated with adjusted risk ratios (aRRs). The aRR for MS given an AHI ⩾ 5 during pregnancy was 1.44 (95% confidence interval [CI], 1.08-1.93), but no association with HTN was found. ODI ⩾ 5 in pregnancy was associated with both an increased risk for HTN (aRR, 2.02; 95% CI, 1.30-3.14) and MS (aRR, 1.53; 95% CI, 1.19-1.97). Participants with an AHI ⩾ 5 in pregnancy that persisted after delivery were at higher risk for both HTN (aRR, 3.77; 95% CI, 1.84-7.73) and MS (aRR, 2.46; 95% CI, 1.59-3.76). Similar associations were observed for persistent ODI ⩾ 5 after delivery. An AHI ⩾ 5 in pregnancy was associated with an increased risk of MS. An ODI ⩾ 5 in pregnancy was significantly associated with both HTN and MS. Participants with persistent elevations in AHI and ODI during pregnancy and at 2-7 years after delivery were at the highest risk for HTN and MS. Clinical trial registered with www.clinicaltrials.gov (NCT02231398).
关于在妊娠和/或分娩后发现的睡眠呼吸障碍(SDB)对健康的影响,目前仍存在知识空白。本研究旨在确定妊娠和/或分娩后的 SDB 是否与高血压(HTN)和代谢综合征(MS)相关。nuMoM2b-HHS(未产妇妊娠结局研究:监测孕妇心脏健康研究)( = 4508)最初招募了参与者在其第一次怀孕期间。参与者在怀孕后 2-7 年内返回接受检查。本研究检查了在第一次怀孕期间接受 SDB 评估的亚组( = 1964)和产后重复 SDB 评估的亚组( = 1222)。考虑了两种 SDB 定义:)呼吸暂停-低通气指数(AHI)≥5 和)氧减饱和指数(ODI)≥5。使用调整后的风险比(aRR)评估 SDB 与新发 HTN 和 MS 之间的关联。在怀孕期间 AHI≥5 时,MS 的 aRR 为 1.44(95%置信区间 [CI],1.08-1.93),但与 HTN 无关联。怀孕期间 ODI≥5 与 HTN(aRR,2.02;95%CI,1.30-3.14)和 MS(aRR,1.53;95%CI,1.19-1.97)的风险增加相关。在怀孕期间 AHI≥5 且产后仍持续存在的参与者,患 HTN(aRR,3.77;95%CI,1.84-7.73)和 MS(aRR,2.46;95%CI,1.59-3.76)的风险更高。产后 ODI≥5 也存在类似的关联。在怀孕期间 AHI≥5 与 MS 的风险增加相关。在怀孕期间 ODI≥5 与 HTN 和 MS 显著相关。在怀孕期间和怀孕后 2-7 年内 AHI 和 ODI 持续升高的参与者,患 HTN 和 MS 的风险最高。该临床试验已在 www.clinicaltrials.gov 注册(NCT02231398)。